Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 1, 2018
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
Fri, September 28, 2018
[ Fri, Sep 28th 2018
] - WOPRAI
[ Fri, Sep 28th 2018
] - WOPRAI
[ Fri, Sep 28th 2018
] - WOPRAI
David Lebovitz Maintained (ALNY) at Hold with Decreased Target to $87 on, Sep 28th, 2018
David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $93 to $87 on, Sep 28th, 2018.
David has made no other calls on ALNY in the last 4 months.
There are 6 other peers that have a rating on ALNY. Out of the 6 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with David
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $117 on, Thursday, September 13th, 2018
- Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $147 on, Monday, August 13th, 2018
- Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $123 on, Monday, August 13th, 2018
- Christopher Marai of "Nomura" Maintained at Sell with Decreased Target to $73 on, Monday, August 13th, 2018
- Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $125 on, Monday, August 13th, 2018
- Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $230 on, Monday, August 13th, 2018
